换一批Randomized clinical trial comparing the efficacy and safety of treatment with the once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor omarigliptin or the once-daily DPP-4 inhibitor sitagliptin in patients with type 2 diabetes inadequately controlled on metformin monotherapy.
第一作者：
Ronald,Goldenberg
第一单位：
LMC Diabetes & Endocrinology, Toronto, Ontario, Canada.
作者：
医学主题词
老年人(Aged);血糖(Blood Glucose);糖尿病, 2型(Diabetes Mellitus, Type 2);二肽基肽酶Ⅳ抑制剂(Dipeptidyl-Peptidase IV Inhibitors);双盲法(Double-Blind Method);药物疗法, 联合(Drug Therapy, Combination);女(雌)性(Female);杂环化合物, 2环(Heterocyclic Compounds, 2-Ring);人类(Humans);降血糖药(Hypoglycemic Agents);最小二乘法分析(Least-Squares Analysis);男(雄)性(Male);二甲双胍(Metformin);中年人(Middle Aged);吡喃类(Pyrans);治疗结果(Treatment Outcome)
DOI
10.1111/dom.12832
PMID
28093853
发布时间
2024-03-24
- 浏览29
Diabetes, obesity & metabolism
394-400页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文
